Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. TGT
2. EL
3. BILL
4. MRK
5. MRNA
6. ADI
7. LOW
8. TJX
9. DE
10. COTY

Go back to Kiora Pharmaceuticals Licenses South Korean Ophthalmic Development and Commercialization Rights for KIO-301 to Chong Kun Dang Pharmaceutical Corporation
(NASDAQ: KPRX) Delayed: 2.58 -0.02 (0.77%)
Previous Close $2.60    52 Week High $ 
Open $2.54    52 Week Low $ 
Day High $2.58    P/E N/A 
Day Low $2.54    EPS $ 
Volume 3,732